Almost 800 medications—including Ozempic and Mounjaro—had a median list price increase of 4.5% this month, according to a Wall Street Journal report, meaning copays may increase for consumers. An ...

January is usually a big month for hiking the list prices of drugs in the US—and it looks like 2024 will be no different. Pharmaceutical companies plan to raise the US list prices of more than 500 ...

The Department of Health and Human Services (HHS) has released a new list of Medicare Part B drugs that will have lower coinsurance rates from April 1 to June 30 if drugmakers raise their prices ...

Some Americans may have to shell out more this year for Ozempic and Mounjaro, two wildly popular diabetes medications also used for weight loss. Drugmakers raised the list prices of the two drugs, ...

A recent study highlighted the prevalence of recreational drug use among American teenagers, revealing that an estimated 2.9 million Americans under 18 have used marijuana in recent years. The ...

Popular diabetes drugs such as Ozempic and Trulicity are among 25 drugs Medicare has spent the most on but hasn't yet selected for price negotiation, according to a report released Thursday. The ...

The Biden administration, in its last full weekday in office, announced the next 15 drugs up for Medicare price negotiation. Blockbuster diabetes drug Ozempic is on the list. That means the federal ...

The Centers for Medicare and Medicaid Services announced Friday that 64 Part B drugs will have a reduced price for Medicare patients at the pharmacy counter in the first quarter of 2025. CMS said ...